Mid- and Long-term Outcomes of Custom-made Aortic Devices

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Mar 9, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the long-term effects of a specific treatment called Thoracic Endovascular Aortic Repair (TEVAR) using custom-made devices for people with thoracic aortic diseases, like thoracic aortic aneurysms. The goal is to see how well these devices work over time and how they affect patients’ health.

To participate in this trial, you need to be between the ages of 65 and 74 and diagnosed with a thoracic aortic disease. However, if you need urgent treatment for your condition, you won’t be eligible. If you join the study, you can expect to have regular follow-ups to monitor your health and the performance of the device. This trial is currently looking for participants, and your involvement could help improve future treatments for this serious condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Thoracic Aortic Disease
• Exclusion Criteria:
• • Urgent/Emergent treatment